세계의 비타민 B12(코발라민, 시아노코발라민) 시장 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)
Vitamin B12 (Cobalamin, Cyanocobalamin) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
상품코드:1873374
리서치사:QYResearch
발행일:2025년 10월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 비타민 B12(코발라민, 시아노코발라민) 시장 규모는 2024년에 4억 4,100만 달러로 추정되며, 2025년부터 2031년까지 예측 기간 동안 CAGR 2.9%로 성장하여 2031년까지 5억 3,700만 달러로 확대될 것으로 예측됩니다.
본 보고서는 비타민 B12(코발라민, 시아노코발라민)에 대한 최근 관세 조정과 국제적인 전략적 대응 조치에 대해 국경 간 산업 발자국, 자본 배분 패턴, 지역 경제의 상호의존성, 공급망 재편 등의 관점에서 종합적인 평가를 제공합니다.
비타민 B12는 우리 몸의 신경세포와 혈액세포를 건강하게 유지하고 모든 세포의 유전물질인 DNA의 생성을 돕는 영양소다. 또한, 피로감이나 쇠약감을 유발하는 거대적아구성 빈혈이라는 빈혈 예방에도 도움이 됩니다.
비타민 B12 시장은 건강과 영양에 대한 소비자의 인식이 높아지고, 현대인의 식습관과 생활습관에 따른 결핍증에 대처하는 것이 중요하다는 인식이 확산되면서 성장세를 보이고 있습니다. 비타민 B12는 신경 기능, 적혈구 형성, DNA 합성에 중요한 역할을 하며, 전반적인 건강 유지에 필수적인 영양소입니다. 건강에 대한 관심이 높은 일반인뿐만 아니라 비건, 채식주의자, 노인 등 비타민B12 결핍증에 취약한 특정 계층의 수요도 증가하고 있습니다. 이에 따라 세계 시장에서 비타민 B12 강화 식품, 건강보조식품, 의약품 제제의 개발 및 소비가 확대되고 있습니다.
공급 측면에서는 합성공정이나 발효공정을 통해 생산되는 시아노코발라민, 메틸코발라민 등 다양한 형태의 비타민B12가 시장에 유통되고 있습니다. 각 제조사들은 보다 효율적이고 지속가능한 생산기술에 대한 투자를 진행하는 한편, 지역별로 상이한 규제 프레임워크에 대응하기 위해 노력하고 있습니다. E-Commerce와 소비자 직접 판매 브랜드의 보급 확대는 유통 경로를 재구성하여 비타민 B12 제품에 대한 보다 광범위하고 편리한 접근을 가능하게 하고 있습니다. 공중 보건 정책에서 미량영양소 보충의 중요성을 지속적으로 강조하는 가운데, 비타민 B12 시장은 앞으로도 역동적이고 혁신 주도적인 성장을 지속할 것으로 예상됩니다.
이 보고서는 비타민B12(코발라민, 시아노코발라민) 세계 시장에 대해 총 판매량, 매출, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역/국가별, 유형별, 용도별 분석을 종합적으로 제시하는 것을 목적으로 합니다.
비타민B12(코발라민, 시아노코발라민)의 시장 규모 추정 및 예측은 판매량(천 단위) 및 매출액(백만 달러)으로 제시되며, 2024년을 기준 연도, 2020년에서 2031년까지의 과거 데이터와 예측 데이터를 포함하는 시장 규모 추정 및 예측을 제공합니다. 정량적 분석과 정성적 분석을 통해 독자들이 비타민B12(코발라민, 시아노코발라민)에 대한 비즈니스/성장 전략을 수립하고, 시장 경쟁을 평가하고, 현재 시장에서의 포지셔닝을 분석하고, 비타민B12(코발라민, 시아노코발라민)에 대한 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 도와드립니다.
시장 세분화
기업별
Luitpold Pharmaceuticals(Daiichi Sankyo)
Endo International
Sanofi-Aventis
Jamieson
Novartis
Teva(Actavis)
Merck
Mylan
Bayer HealthCare
Pfizer
ANGELINI
Biological E
CCEPCD
Huaxin Pharmaceutical
RLG Group
유형별 부문
시아노코발라민 주사제
시아노코발라민 경구제
시아노코발라민 스프레이
용도별 부문
병원
진료소
약국
기타
지역별
북미
미국
캐나다
아시아태평양
중국
일본
한국
동남아시아
인도
호주
기타 아시아태평양
유럽
독일
프랑스
영국
이탈리아
네덜란드
북유럽 국가
기타 유럽
라틴아메리카
멕시코
브라질
기타 라틴아메리카
중동 및 아프리카
튀르키예
사우디아라비아
아랍에미리트
기타 중동 및 아프리카
KSM
영문 목차
영문목차
The global market for Vitamin B12 (Cobalamin, Cyanocobalamin) was estimated to be worth US$ 441 million in 2024 and is forecast to a readjusted size of US$ 537 million by 2031 with a CAGR of 2.9% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Vitamin B12 (Cobalamin, Cyanocobalamin) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Vitamin B12 is a nutrient that helps keep the body's nerve and blood cells healthy and helps make DNA, the genetic material in all cells. Vitamin B12 also helps prevent a type of anemia called megaloblastic anemia that makes people tired and weak.
The Vitamin B12 market is driven by growing consumer awareness about health, nutrition, and the importance of addressing deficiencies linked to modern diets and lifestyles. Vitamin B12 plays a crucial role in nerve function, red blood cell formation, and DNA synthesis, making it essential for overall well-being. Demand is increasing not only from the general health-conscious population but also from specific groups such as vegans, vegetarians, and the elderly, who are more prone to B12 deficiency. This has led to a rise in the development and consumption of B12-fortified foods, dietary supplements, and pharmaceutical formulations across global markets.
On the supply side, the market includes various forms of Vitamin B12, such as cyanocobalamin and methylcobalamin, produced through synthetic and fermentation-based processes. Manufacturers are investing in more efficient and sustainable production technologies, while also navigating regulatory frameworks that differ by region. The growing penetration of e-commerce and direct-to-consumer brands is also reshaping distribution channels, allowing for wider and more convenient access to B12 products. As public health initiatives continue to highlight the importance of micronutrient supplementation, the Vitamin B12 market is expected to remain dynamic and innovation-driven.
This report aims to provide a comprehensive presentation of the global market for Vitamin B12 (Cobalamin, Cyanocobalamin), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Vitamin B12 (Cobalamin, Cyanocobalamin) by region & country, by Type, and by Application.
The Vitamin B12 (Cobalamin, Cyanocobalamin) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vitamin B12 (Cobalamin, Cyanocobalamin).
Market Segmentation
By Company
Luitpold Pharmaceuticals (Daiichi Sankyo)
Endo International
Sanofi-Aventis
Jamieson
Novartis
Teva (Actavis)
Merck
Mylan
Bayer HealthCare
Pfizer
ANGELINI
Biological E
CCEPCD
Huaxin Pharmaceutical
RLG Group
Segment by Type
Cyanocobalamin Injection
Cyanocobalamin Oral
Cyanocobalamin Spray
Segment by Application
Hospitals
Clinics
Drugstore
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Vitamin B12 (Cobalamin, Cyanocobalamin) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Vitamin B12 (Cobalamin, Cyanocobalamin) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Vitamin B12 (Cobalamin, Cyanocobalamin) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
2.9.2 Global 5 and 10 Largest Manufacturers by Vitamin B12 (Cobalamin, Cyanocobalamin) Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vitamin B12 (Cobalamin, Cyanocobalamin) as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cyanocobalamin Injection
3.1.2 Cyanocobalamin Oral
3.1.3 Cyanocobalamin Spray
3.2 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value by Type
3.2.1 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value, by Type (2020-2031)
3.2.3 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value, by Type (%) (2020-2031)
3.3 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Volume by Type
3.3.1 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Volume, by Type (2020-2031)
3.3.3 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Volume, by Type (%) (2020-2031)
3.4 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Drugstore
4.1.4 Others
4.2 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value by Application
4.2.1 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value, by Application (2020-2031)
4.2.3 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value, by Application (%) (2020-2031)
4.3 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Volume by Application
4.3.1 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Volume, by Application (2020-2031)
4.3.3 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Volume, by Application (%) (2020-2031)
4.4 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value by Region
5.1.1 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value by Region (2020-2025)
5.1.3 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value by Region (2026-2031)
5.1.4 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value by Region (%), (2020-2031)
5.2 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Volume by Region
5.2.1 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Volume by Region (2020-2025)
5.2.3 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Volume by Region (2026-2031)
5.2.4 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Volume by Region (%), (2020-2031)
5.3 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value, 2020-2031
5.4.2 North America Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value, 2020-2031
5.5.2 Europe Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value, 2020-2031
5.6.2 Asia Pacific Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value, 2020-2031
5.7.2 South America Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value, 2020-2031
5.8.2 Middle East & Africa Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Value and Sales Volume
